Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

165.90
Delayed Data
As of Feb 23
 +8.31 / +5.27%
Today’s Change
84.39
Today|||52-Week Range
174.96
+10.70%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$42.1B

Company Description

Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. It focuses on development and commercializing therapies for the treatment of cystic fibrosis; infectious diseases, including viral infections, such as influenza, and bacterial infections; autoimmune diseases, such as rheumatoid arthritis; cancer, inflammatory bowel disease; and neurological disorders, including pain, Huntington's disease and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Contact Information

Vertex Pharmaceuticals, Inc.
50 Northern Avenue
Boston Massachusetts 02210
P:(617) 341-6100
Investor Relations:
(617) 444-6108

Employees

Shareholders

Mutual fund holders58.09%
Other institutional38.43%
Individual stakeholders1.04%

Top Executives

Jeffrey M. LeidenChairman, President & Chief Executive Officer
Ian F. SmithChief Operating Officer & Executive Vice President
Thomas GraneyChief Financial Officer & Senior Vice President
David Matthew AltshulerChief Scientific Officer & EVP-Global Research
Jeffrey A. ChodakewitzChief Medical Officer & Executive Vice President